OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
71
Results
Show all
Save search
Copy query
Show results for
Unknown
(68)
Proteomics
(3)
Organisms
Alphavirus
(2)
Anemia
(2)
Archaea
(2)
Bacteria
(2)
Betaherpesvirinae
(2)
Borrelia
(2)
Chlorella vulgaris
(2)
Clostridium perfringens
(2)
Dengue virus
(2)
Enterovirus A71
(2)
Eukaryota
(2)
Hepatitis B virus
(2)
Human alphaherpesvirus 1
(2)
Human betaherpesvirus 5
(2)
Influenza A virus
(2)
Influenza C virus
(2)
Japanese encephalitis virus group
(2)
Kamptonema sp.
(2)
Listeria monocytogenes
(2)
Mammarenavirus
(2)
Miscanthus x giganteus
(2)
Mycobacterium tuberculosis
(2)
Orthoflavivirus
(2)
Panicum virgatum
(2)
Pseudomonas aeruginosa
(2)
Rattus
(2)
Severe acute respiratory syndrome coronavirus 2
(2)
Staphylococcus aureus
(2)
Streptococcus pneumoniae
(2)
Viruses
(2)
Repository
pride
(2)
MassIVE
(1)
Tissue
Permanent cell line cell
(1)
Disease
Lung cancer
(1)
Malignant neoplasm of ovary
(1)
Pancreatic cancer
(1)
Technology Type
Mass Spectrometry
(2)
Affinity purification coupled with mass spectrometry proteomics
(1)
Gel-based experiment
(1)
Instrument Platform
Orbitrap Exploris 480
(1)
Publication Date
2020
(1)
2026
(1)
2024
(1)
Release Date
2021
(14)
2024
(12)
2022
(11)
2023
(10)
2025
(9)
2020
(4)
2019
(2)
2026
(1)
2018
(1)
2017
(1)
2016
(1)
2015
(1)
2011
(1)
Lab affiliation
Quantitative Biosciences Institute (QBI), University of California, San Francisco, San Francisco, CA USA J. David Gladstone Institutes, San Francisco, San Francisco, CA, USA Department of Bionengineer and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, USA
(1)
University of Nebraska Medical Center
(1)
Previous
page
1 / 8
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
8
Next
page
Sort
by:
Relevance
Page size
10
Molecular implications of MUC5AC-CD44 axis in colorectal cancer progression and chemoresistance.
Not available
S-EPMC7041280
|
biostudies-literature
Cite
Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells.
Not available
S-EPMC6582495
|
biostudies-literature
Cite
PGC1α-Mediated Metabolic Reprogramming Drives the Stemness of Pancreatic Precursor Lesions.
Not available
S-EPMC8709878
|
biostudies-literature
Cite
Reduction in O-glycome induces differentially glycosylated CD44 to promote stemness and metastasis in pancreatic cancer.
Not available
S-EPMC8727507
|
biostudies-literature
Cite
Elevated PAF1-RAD52 Axis Confers Chemoresistance to Human Cancers
To identify a common protein that interacts with PAF1 in ovarian cancer, lung Cancer, and pancreatic cancer to mediate chemoresistance.
ORGANISM(S):
Homo sapiens (Human)
2024-01-26
|
PXD039281
|
Pride
Ovarian cancer
Paf1
Pancreatic cancer
Lung cancer
Rad52
Cite
Macrophage-Derived Neuropilin-2 Exhibits Novel Tumor-Promoting Functions.
Not available
S-EPMC6168405
|
biostudies-literature
Cite
Selective inhibition of stemness through EGFR/FOXA2/SOX9 axis reduces pancreatic cancer metastasis.
Not available
S-EPMC7848971
|
biostudies-literature
Cite
Elevated PAF1-RAD52 axis confers chemoresistance to human cancers.
Not available
S-EPMC10374878
|
biostudies-literature
Cite
Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma.
Not available
S-EPMC10041665
|
biostudies-literature
Cite
Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in pancreatic ductal adenocarcinoma.
Not available
S-EPMC9841597
|
biostudies-literature
Cite
Previous
page
1 / 8
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
8
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
